Online pharmacies may soon be offering a new drug for an eye condition related to diabetes. The US Food and Drug Administration is currently reviewing the new drug application for Iluvien, filed by pharmaceutical company Alimera Sciences. If that happens, it will be a positive development for patients with diabetic macular edema (DME) who buy medication online. This may turn out to be a prescription drug, though, so approval from a doctor is still important.

DME affects more than 75,000 people every year. It affects a tenth of diabetics and can cause blindness if it isn’t treated properly. There are several treatment options for DME, including laser treatment, but Iluvien will be the first DME medicine in the United States. Although it isn’t offered in online pharmacies just yet, DME patients are probably going to be able to use it in a few years, after FDA approval. Hopefully, it will be made available to those who buy medication online.

Related posts:

1. Application for MS Treatment Accepted by FDA
2. Traditional Chinese Medicine Passes FDA Drug Approval Phase II
3. Generic Clonidine Production Gets Approval from FDA
4. Hemophilia Syringe by Pfizer Approved by FDA
5. FDA Approves New Hypertension Medicine Tekamlo